Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2026)

Organogenesis Holdings' Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $45.3 million for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax rose 11.31% year-over-year to $45.3 million; the TTM figure through Mar 2026 stood at $45.3 million (up 11.31% YoY), while the FY2025 annual figure was $30.0 million, down 24.07% from the prior year.
• Long-Term Deferred Tax was $45.3 million for Q1 2026 at Organogenesis Holdings, up from $30.0 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $45.6 million in Q3 2025 to a low of $28.0 million in Q4 2023.
• Historically, Long-Term Deferred Tax has averaged $34.4 million across 5 years, with a median of $32.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Long-Term Deferred Tax jumped 177644.44% in 2022, then dropped 24.07% in 2025.
• A 5-year view of Long-Term Deferred Tax shows it stood at $30.0 million in 2022, then decreased by 6.7% to $28.0 million in 2023, then jumped by 40.93% to $39.5 million in 2024, then decreased by 24.07% to $30.0 million in 2025, then jumped by 51.3% to $45.3 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $45.3 million (Q1 2026), $30.0 million (Q4 2025), and $45.6 million (Q3 2025), per Business Quant data.